JESUS VALLEJO to Lipopolysaccharides
This is a "connection" page, showing publications JESUS VALLEJO has written about Lipopolysaccharides.
Connection Strength
0.309
-
Differential role of Toll-interleukin 1 receptor domain-containing adaptor protein in Toll-like receptor 2-mediated regulation of gene expression of hepatic cytokines and drug-metabolizing enzymes. Drug Metab Dispos. 2011 May; 39(5):874-81.
Score: 0.081
-
Targeted gene silencing of tumor necrosis factor attenuates the negative inotropic effects of lipopolysaccharide in isolated contracting cardiac myocytes. Tex Heart Inst J. 2008; 35(1):16-21.
Score: 0.066
-
CD14-deficient mice are protected against lipopolysaccharide-induced cardiac inflammation and left ventricular dysfunction. Circulation. 2002 Nov 12; 106(20):2608-15.
Score: 0.046
-
Escherichia coli LPS-induced LV dysfunction: role of toll-like receptor-4 in the adult heart. Am J Physiol Heart Circ Physiol. 2002 Jun; 282(6):H2316-23.
Score: 0.045
-
In vivo expression of proinflammatory mediators in the adult heart after endotoxin administration: the role of toll-like receptor-4. J Infect Dis. 2001 Jun 01; 183(11):1617-24.
Score: 0.041
-
Interleukin-6 production by human neonatal monocytes stimulated by type III group B streptococci. J Infect Dis. 1996 Aug; 174(2):332-7.
Score: 0.030